A detailed history of Banque Pictet & Cie Sa transactions in Abbott Laboratories stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 458,932 shares of ABT stock, worth $53.6 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
458,932
Previous 447,159 2.63%
Holding current value
$53.6 Million
Previous $46.5 Million 12.61%
% of portfolio
0.4%
Previous 0.42%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$100.07 - $118.13 $1.18 Million - $1.39 Million
11,773 Added 2.63%
458,932 $52.3 Million
Q2 2024

Jul 25, 2024

BUY
$100.73 - $112.44 $4.71 Million - $5.25 Million
46,717 Added 11.67%
447,159 $46.5 Million
Q1 2024

May 06, 2024

SELL
$109.52 - $120.96 $815,595 - $900,789
-7,447 Reduced 1.83%
400,442 $45.5 Million
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $430,567 - $527,049
4,774 Added 1.18%
407,889 $44.9 Million
Q3 2023

Nov 02, 2023

SELL
$95.53 - $114.62 $1.77 Million - $2.12 Million
-18,503 Reduced 4.39%
403,115 $39 Million
Q2 2023

Aug 04, 2023

BUY
$100.78 - $112.29 $15.9 Million - $17.8 Million
158,238 Added 60.08%
421,618 $46 Million
Q1 2023

May 01, 2023

SELL
$96.86 - $114.01 $766,162 - $901,819
-7,910 Reduced 2.92%
263,380 $26.7 Million
Q4 2022

Feb 06, 2023

BUY
$95.06 - $111.52 $705,535 - $827,701
7,422 Added 2.81%
271,290 $0
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $1.14 Million - $1.32 Million
-11,813 Reduced 4.29%
263,868 $25.5 Billion
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $1.88 Million - $2.27 Million
-18,424 Reduced 6.26%
275,681 $30 Million
Q1 2022

May 04, 2022

SELL
$114.02 - $139.04 $1.16 Million - $1.42 Million
-10,184 Reduced 3.35%
294,105 $34.8 Million
Q4 2021

Feb 02, 2022

BUY
$115.53 - $141.46 $10.2 Million - $12.5 Million
88,206 Added 40.82%
304,289 $42.8 Million
Q3 2021

Nov 10, 2021

SELL
$116.66 - $129.06 $1.07 Million - $1.19 Million
-9,214 Reduced 4.09%
216,083 $25.5 Million
Q2 2021

Aug 12, 2021

SELL
$105.79 - $124.53 $5.81 Million - $6.84 Million
-54,917 Reduced 19.6%
225,297 $26.1 Million
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $2.22 Million - $2.61 Million
20,359 Added 7.83%
280,214 $33.6 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $9.03 Million - $9.84 Million
85,996 Added 49.46%
259,855 $28.5 Million
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $666,772 - $809,746
7,276 Added 4.37%
173,859 $18.9 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $934,153 - $1.2 Million
12,200 Added 7.9%
166,583 $15.2 Million
Q1 2020

Apr 30, 2020

BUY
$62.82 - $91.86 $846,436 - $1.24 Million
13,474 Added 9.56%
154,383 $12.2 Million
Q4 2019

Feb 03, 2020

BUY
$78.51 - $87.4 $568,019 - $632,339
7,235 Added 5.41%
140,909 $12.2 Million
Q3 2019

Nov 08, 2019

SELL
$81.84 - $88.74 $1.3 Million - $1.41 Million
-15,900 Reduced 10.63%
133,674 $11.2 Million
Q2 2019

Aug 07, 2019

SELL
$72.88 - $85.0 $1.93 Million - $2.25 Million
-26,500 Reduced 15.05%
149,574 $12.6 Million
Q1 2019

May 02, 2019

SELL
$66.22 - $80.06 $2.34 Million - $2.83 Million
-35,373 Reduced 16.73%
176,074 $14.1 Million
Q4 2018

Jan 31, 2019

SELL
$65.56 - $74.27 $401,882 - $455,275
-6,130 Reduced 2.82%
211,447 $15.3 Million
Q3 2018

Nov 07, 2018

BUY
$60.81 - $73.36 $4,256 - $5,135
70 Added 0.03%
217,577 $16 Million
Q2 2018

Aug 09, 2018

SELL
$57.57 - $63.54 $6.62 Million - $7.3 Million
-114,944 Reduced 34.57%
217,507 $13.3 Million
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $2.32 Million - $2.63 Million
-41,287 Reduced 11.05%
332,451 $19.9 Million
Q4 2017

Feb 09, 2018

SELL
$53.68 - $57.47 $1.61 Million - $1.72 Million
-29,996 Reduced 7.43%
373,738 $21.3 Million
Q3 2017

Nov 07, 2017

SELL
$48.06 - $53.64 $1.52 Million - $1.69 Million
-31,528 Reduced 7.24%
403,734 $21.5 Million
Q2 2017

Aug 09, 2017

BUY
N/A
435,262
435,262 $21.2 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.